5,055 followers
A new antibody treatment targeting #ProstateCancer: find out more about Prof Russell's preclinical study using Miltuximab®, with the support of #TRI's preclinical testing facility. Next step: Phase I clinical trial in patients. ▶ https://t.co/H8oghcJLhf